In Brief
In lupus, sustained IFNa signaling leads to anti-DNA autoimmunity. Gkirtzimanaki et al. propose that excessive IFNa damages mitochondrial respiration, leading to oxidative stress that impairs lysosomal degradation and obstructs autophagic clearance. Undegraded mtDNA escapes in the cytoplasm and is sensed, priming monocytes cellautonomously to initiate an anti-viral-like response against self-DNA.
SUMMARY
Interferon a (IFNa) is a prompt and efficient orchestrator of host defense against nucleic acids but upon chronicity becomes a potent mediator of autoimmunity. Sustained IFNa signaling is linked to pathogenesis of systemic lupus erythematosus (SLE), an incurable autoimmune disease characterized by aberrant self-DNA sensing that culminates in anti-DNA autoantibody-mediated pathology. IFNa instructs monocytes differentiation into autoinflammatory dendritic cells (DCs) than potentiates the survival and expansion of autoreactive lymphocytes, but the molecular mechanism bridging sterile IFNa-danger alarm with adaptive response against self-DNA remains elusive. Herein, we demonstrate IFNa-mediated deregulation of mitochondrial metabolism and impairment of autophagic degradation, leading to cytosolic accumulation of mtDNA that is sensed via stimulator of interferon genes (STING) to promote induction of autoinflammatory DCs. Identification of mtDNA as a cell-autonomous enhancer of IFNa signaling underlines the significance of efficient mitochondrial recycling in the maintenance of peripheral tolerance. Antioxidant treatment and metabolic rescue of autolysosomal degradation emerge as drug targets in SLE and other IFNa-related pathologies.
INTRODUCTION
Systemic lupus erythematosus (SLE) is a complex autoimmune inflammatory disease characterized by multiple pathophenotypes whereby interferon a (IFNa)-driven immunologic alterations culminate into persistent self-directed immune responses against autologous nucleic acids. Excessive and intractable tissue damage caused by autoantibodies, especially by antidouble-stranded DNA (dsDNA) immunoglobulin Gs (IgGs), or immune-complex depositions, affects various organs leading to increased morbidity and mortality (Weckerle et al., 2011) . Genome-wide association studies (GWAS) studies reveal a genetic predisposition toward type I IFN activity in SLE with familial chilblain lupus considered as interferonopathy (Crow and Manel, 2015) and functional studies confirm its role in breakdown of peripheral tolerance and autoimmunity development (Crow, 2014; Liao et al., 2016) . In support, hepatitis-C and leukemia patients treated with IFNa frequently develop a lupus-like syndrome with high titers of anti-dsDNA autoantibodies.
IFNa signaling and activation of nucleic acid-sensing and clearance pathways are intertwined (Shrivastav and Niewold, 2013) , orchestrating antiviral immunity such as the differentiation of monocytes to potent antigen presenting dendritic cells (DCs) with increased capacity to drive T and B cell responses (Blanco et al., 2001; Ding et al., 2006; Jegerlehner et al., 2007; Ma et al., 2013; Pascual et al., 2006; Rö nnblom and Pascual, 2008) . In SLE, circulating monocytes are already differentiated into DCs with their function shaped by IFNa (Blanco et al., 2001; Rö nnblom and Pascual, 2008) . These IFNa-DCs exhibit increased HLA-DR, CD86, and BAFF expression, activate autoreactive T cells, and promote the expansion and differentiation of autoreactive B cells, therefore bridging innate danger sensing with adaptive autoimmune response (Gujer et al., 2011) . However, the molecular mechanism(s) driving IFNa-mediated autoreactivity in SLE antigen-presenting cells (APCs) remain(s) elusive.
Autophagy is an evolutionarily conserved membrane-trafficking mechanism by which cells deliver cytoplasmic substrates to lysosomes for their recycling to maintain cellular metabolic equilibrium and homeostasis (Klionsky et al., 2011) . Emerging literature implicates autophagy in intracellular danger sensing, antigen processing, and delivery for presentation in APCs (Alissafi et al., 2017; Rö nnblom and Pascual, 2008) . Moreover, it regulates the activation and differentiation of APCs through metabolic adaptation and maintenance of mitochondrial homeostasis (Ravi et al., 2014; Zhang et al., 2012) . Sequestration and successful clearance of damaged mitochondria by autophagy (mitophagy) suppresses mitochondrial reactive oxygen species (mtROS) accumulation and prevents inflammation and generation of autoantigens by intracellular oxidation (Minton, 2016) . Many antigens implicated in SLE pathology have undergone oxidative modification (dsDNA, HDL, b2GPI, Ro) that shows striking correlation with disease activity and organ damage (Perl, 2013) . Additionally, failure of autophagic digestion of mitochondrial components such as mtDNA can lead to their cytosolic leakage and cause inflammation (Nakai et al., 2007) . The highly immunogenic properties of mtDNA, an unmethylated dsDNA species of bacterial origin (Pisetsky, 2016; Zhang et al., 2010) , when it is not properly recycled (Caielli et al., 2016; Oka et al., 2012) , suggest that it can be perceived as a strong candidate to drive SLE autoreactivity.
In this study, we asked whether deregulated autophagy may be involved in the IFNa-mediated immunogenicity of monocytes in SLE and whether this is mediated by defects in their cell autonomous recycling that could result in activation of cytoplasmic DNA sensing. Our findings delineate that lupus characteristic IFNa signature in monocytes of active, untreated SLE patients is linked to aberrant mitochondrial metabolism, altered lysosomal pH, and defective autophagic degradation that results in cytoplasmic accumulation of mtDNA. Innate immune receptor stimulator of interferon genes (STING) senses it and drives differentiation of monocytes into autoreactive DCs to promote intracellular DNA-mediated, type I interferon-dependent immunity. Deciphering the role of IFNa in cell autonomous generation and sensing of self-antigens in lupus monocytes will provide us with important insights that may lead to better designed drug targeting to tame SLE autoimmunity.
RESULTS

SLE Monocytes Display Increased Autophagosome
Formation but Defective Autolysosomal Degradation GWAS in SLE peripheral blood mononuclear cells (PBMCs) have identified ATG16L1, ATG5, ATG7, and IRGM autophagy genes as susceptibility loci Zhou et al., 2011) . To understand the regulation of the autophagic flux in freshly isolated CD14 + monocytes of active, untreated SLE patients (Table S1) , we monitored the expression and subcellular localization of indispensable autophagy components (Klionsky et al., 2016) , namely the first ubiquitin-like conjugation system that is necessary for elongation of phagophore membrane (Atg5-Atg12), the second conjugation system that is required for autophagosome formation (PE-LC3B), the sequestrator of substrates to be cleared (SQSTM1/P62), and the acidic compartment for the digestion of autophagy substrates, the lysosome (LAMP1). As evidenced by the transcriptional upregulation of ATG5, the enhanced content in lipidated LC3B form and the presence of Figures 1B-1D ), suggests that proper autolysosomal resolution may be obstructed. Defective autolysosomal function can be either due to impaired autophagosome-to-lysosome fusion or ineffective acidification. Because LAMP1 and LC3B puncta were found to colocalize in SLE monocytes ( Figure 1D ), autophago-lysosomal fusion seems to be unaffected. Instead, lysosomal acidity was found to be compromised as Lysotracker Red-DND99 (LTR), a fluorophore linked to a weak base that is only partially protonated at neutral pH, exhibited significantly weaker intensity in SLE monocytes ( Figure 1E ). This alteration functionally affects lysosomal enzymes as indicated by the decreased cathepsin D activity ( Figure 1F ). Together, these results suggest that SLE monocytes harbor a pool of autophagosomes fused with lysosomes that are not properly acidified to digest damaged intracellular components, thus potentiating the accumulation of ineffectively cleared intracellular waste.
IFNa Signaling Impairs the Completion of Autophagy and Enhances the Immunogenic Potential of Monocytes
To dissect whether the observed defects on autophagy completion are inherent in SLE monocytes or mediated by soluble factors of inflammatory milieu, we cultured CD14 + monocytes from healthy donors with serum (10% v/v) from active SLE (SLEDAI R8), active rheumatoid arthritis (RA) patients, or healthy donors and monitored their autophagic flux. Treatment of healthy monocytes with SLE, but not RA serum, recapitulated the phenotype of SLE monocytes regarding autophagy induction and defective autolysosomal degradation ( Figure S1 ; Tables S1 and S2) . Previous work has shown that monocytes exposed to SLE serum acquire a DC-like phenotype with increased antigen presenting capacity (Blanco et al., 2001) . To explore whether autolysosomal impairment is implicated in this process, we metabolically modulated the autophagic flux in healthy monocytes cultured in the presence of SLE serum with the use of rapamycin, an inhibitor of mechanistic target of rapamycin (mTOR) signaling and potent enhancer of autophagosome formation and autolysosomal degradation (Chen and Fang, 2002) . Indeed, treatment with rapamycin prevented the SLE serum-induced upregulation of membrane HLADR and CD86 ( Figure S1 ), suggesting that SLE serum contents can enhance antigen-presenting capacity of monocytes through autophagy modulation. IFNa is a crucial cytokine that has been documented to drive the DC-like phenotype in SLE monocytes (Blanco et al., 2001 ). In line with this, Cxcl10 mRNA ( Figure S1 ), a known IFNa-inducible gene, was upregulated in SLE serum-treated monocytes, and the extent of their SQSTM1/P62 accumulation correlated positively with serum IFNa concentrations ( Figure S1 ). This prompted us to examine if type I IFN signaling directly affects the autophagic flux of healthy monocytes. We found that autophagy was induced (Figures 2A and 2B ) as early as 4 hr, and the accumulation of SQSTM1/P62 followed and peaked at 18 hr, reaching the levels of accumulation seen upon lysosomal inhibition with hydroxychloroquine (CQ) . Lysosomal function was also compromised in IFNa-treated monocytes as evidenced by the significantly lower LTR intensity ( Figure 2F ) and reduced cathepsin D activity ( Figure 2G ), while rapamycin treatment restored lysosomal degradation upon IFNa signaling ( Figures 2F-2H) .
To examine the functional importance of IFNa-dependent alterations of lysosomal environment that impair autophagy completion in IFNa-DCs, we assessed their MHCII antigen presenting capacity and pro-inflammatory cytokine secretion in the presence of rapamycin. It appears that addition of rapamycin decreased HLADR and CD86 membrane expression and significantly reduced TNFa and interleukin (IL)6 secretion ( Figures 3A  and 3B ). Importantly, IFNa-treated CD14 + monocytes exposed to rapamycin demonstrated markedly reduced capacity to drive naive allogeneic CD4 + T cell proliferation in mixed lymphocyte Figure 3C ). To address whether this effect is similarly significant for the immunoreactivity of SLE monocytes, we treated them ex vivo with rapamycin and performed MLR with naive allogeneic CD4 + T cells. In all cases, mTORC1 (the target of rapamycin inhibition) was found activated in freshly isolated cells from active SLE patients compared to healthy controls ( Figure 3D ), and addition of rapamycin reverted both their higher levels of HLADR and CD86 and their ability to prime T cells ( Figure 3E ) more efficiently than healthy monocytes ( Figure S2 ).
Apart from optimizing lysosomal processing, modulation of mTORC1 activity is known to exert pleiotropic effects on DC differentiation and antigen presentation (Sukhbaatar et al., 2016) . To specifically address that restoration of lysosomal pH can account for the alleviation of IFNa-dependent immunoreactivity of monocytes, we used poly(DL-lactide-co-glycolide) (PLGA) acidic nanoparticles (aNP) instead (Bourdenx et al., 2016) . These biodegradable polymers are known to traffic to lysosomes and prevent lysosomal alkalinization even upon the presence of CQ. Indeed, co-treatment of healthy monocytes with aNPs and IFNa for 18 hr restored lysosomal acidification (Figure 3F) and significantly reduced the membrane expression of HLA-DR and CD86 ( Figure 3G ) and the secretion of IL6 and TNFa ( Figure 3H ).
Together, metabolic rescue of the IFNa-mediated autolysosomal deregulation inhibits the immunogenic potential of monocytes indicating the importance of efficient autophagic clearance for the amelioration of immunoreactivity upon danger signaling.
IFNa-Mediated Lysosomal Dysfunction Impedes Mitochondrial Clearance and Leads to Cell Autonomous mtDNA Accumulation
To decipher how impaired autophagic degradation can drive the immunogenicity of IFNa-shaped monocytes in the absence of an extracellular antigen, we examined the generation of an intra- Results are expressed as mean +SEM. *p < 0.05, **p < 0.005, ***p < 0.0005. Datasets were analyzed using paired Student's t test.
cellular damage-associated molecular pattern (DAMP) that could originate from defective degradation of a cell autonomous autophagy substrate. A prominent cell intrinsic interferogenic DAMP that is physiologically recycled by autophagy is mtDNA (Krysko et al., 2011) . We thus assessed mitochondrial homeostasis and clearance by autophagy (mitophagy) in SLE monocytes. Mitotracker (MTR) staining of monocytes from active, newly diagnosed SLE patients exhibited increased mean fluorescence intensity (MFI) and volume of MTR + areas per cell compared to that observed in healthy monocytes (Figure 4A) . Hyperpolarization of SLE mitochondria (increase in mitochondrial membrane potential [Dc]) (Gergely et al., 2002a) can explain the increase in MTR MFI, but the observed increase in the volume of MTR + areas per cell raised the possibility of alterations in mitochondrial recycling as well. Mitochondrial damage is recognized as indicated by PINK1 upregulation (legend continued on next page) ( Figure 4B ) so mitochondrial recruitment to autophagosomes is induced. To test whether mitophagy is properly completed, we assessed mtDNA quantity; we quantified the relative amount of mtDNA (minArc region) copies calibrated with b2-microglobulin (b2 m) single copy gene of genomic DNA. We found accumulation of mtDNA in SLE monocytes compared to healthy controls ( Figure 4C ), suggesting either an increase in mitochondrial biogenesis or mtDNA escape from mitophagic degradation. Quantity assessment of the mitochondrial protein VDAC1-that is recycled by the proteasome as most of the outer mitochondrial membrane proteins (Geisler et al., 2010 )-revealed no difference between healthy and SLE monocytes ( Figure S3 ). This directed us toward the possibility of ineffective degradation of mitochondrial contents that are cleared by mitophagy. Notably, IFNa signaling induced mitochondrial hyperpolarization as indicated by the increase in intra-mitochondrial aggregates of JC1 dye, as early as 30 min post treatment, and this effect persisted until the 18 hr time point ( Figure 4D ). MTR staining, PINK1 expression, and quantification of nuclear-tomitochondrial DNA m quantification cycle (Cq) ratios further confirmed that IFNa signaling recapitulated the phenotype of SLE monocytes concerning mitochondrial dynamics and mtDNA accumulation ( Figures 4E-4G ). Addition of rapamycin prevented mtDNA accumulation ( Figure 4G ), thus demonstrating that IFNa-dependent defects in the resolution of mitophagy impede mitochondrial clearance and lead to cell autonomous mtDNA accumulation.
Type I IFN Signaling Affects Mitochondrial Metabolism
Leading to Proinflammatory Oxidative Stress-mtROS and ATP Affect Lysosomal pH To dissect the molecular mechanism governing SLE aberrancy in lysosomal degradation we performed next generation sequencing (RNA-seq) in the transcriptome of monocytes from active, untreated SLE patients (Tables S3 and S4 ). Pathway analysis revealed that type I IFN signature (representative genes IFI27, USP18, IFITM1, MX1), increase in antigen presentation and differentiation (MMP10, IL6, CSF3, MIR155HG, SIGLEC-1) coincide with response to oxidative stress and alterations in mitochondrial function and metabolism (ACOT4, CYP19A1, MOXD1, IFI6, GMPR) as well as in endocytic pH and ion channel regulation (IGLL5, CLIC5, ATP10A, KCNH3, CACNB4) ( Figure 5A ; Table S1 ). These results prompted us to formulate the hypothesis that IFNa-mediated deregulation of mitochondrial metabolism affects lysosomal pH, resulting in defective mitochondrial clearance. Lysosomal pH stability is affected by the localization and activity of mTORC1 subunit that functions to couple the cellular metabolic state to lysosomal degradation through ATP sensing (Cang et al., 2013) . After confirming that mTORC1 is activated upon IFNa treatment (Matsumoto et al., 2009 ), we addressed whether aberrant OXPHOS, as evidenced by persistent mitochondrial hyperpolarization, can be coupled with IFNa-dependent lysosomal alkalinization through ATP sensing. We assessed the levels of both ATP and mtROS, in healthy monocytes cultured with IFNa. mtROS levels were increased as early as 2 hr post IFNa treatment whereas ATP levels were reduced, and this effect persisted until 18 hr as evidenced by MitoSOX staining and colorimetric assessment of intracellular ATP concentration ( Figures  5B and 5C ). Scavenging of mtROS with MitoTEMPO prevented the IFNa-mediated decrease in ATP formation and additionally enhanced its production compared to basal levels ( Figure 5C ) and restored lysosomal pH ( Figure 5D ). Addition of rapamycin reverted the aberrant OXPHOS product equilibrium, restoring mtROS production to physiological levels while also increasing ATP levels ( Figures 5B and 5C ). In support, oxygen consumption rate that was significantly lower upon IFNa signaling was restored with the addition of rapamycin or mtROS scavenging ( Figure S6 ). Together, our results suggest the existence of a vicious cycle of defective mitochondrial respiration and oxidative stress that is generated and amplified upon IFNa signaling. Mitochondrial hyperpolarization, indicative of defective OXPHOS, increases the mtROS-to-ATP ratio and this impairs lysosomal degradation, which in turn impedes effective clearance of damaged mitochondria, thus numbing monocytes' capacity to control oxidative stress. To address whether IFNa-mediated effects in mitochondrial respiration drive monocytes inflammatory priming upon IFNa signaling, we scavenged mtROS and assessed their antigen presenting properties. Addition of MitoTEMPO prevented the IFNa-dependent increase of membrane expression of HLA-DR and to a lesser extent of CD86 ( Figure 5E ) and the concomitant IL6 and TNFa secretion ( Figure 5F ), thus ameliorating the effects of pro-inflammatory intracellular oxidative stress.
Autophagy Escape of mtDNA Is Sensed through STING and Primes Monocytes for Autoimmune Responses
Autophagic escape of mtDNA is a cell autonomous trigger that engages antiviral signaling to enhance the expression of a subset of IFN-stimulated genes and can induce inflammation and disease pathology (Oka et al., 2012) . Unmethylated self DNA, whose cytoplasmic release is not related to programmed cell death, can be sensed by TLR9 in endosomes and by cytosolic sensors (DAI, IFI16/P202, DDX41, and cGAS) (de Jong et al., 2010; Klinman et al., 1996; West et al., 2015) that activate the STING adaptor molecule. As (legend on next page) revealed by our RNA-seq data from SLE monocytes of active patients with strong IFNa signature, DNA cytosolic sensors are overexpressed (DAI, IFI16, ZBP1) whereas cGAS, that belongs to the family of IFN-stimulated genes (ISGs) (Ma et al., 2015) , was not differentially expressed. To identify which pathway is engaged during mtDNA sensing upon IFNa signaling and translate it into increased immunogenicity, we silenced TLR9 and STING expression in healthy monocytes, cultured with GMCSF and IL4 or IFNa for 3 days, and measured their antigen presenting capacity. We found that IFNa-mediated increase in HLA À DR + CD86 + monocytes and CXCL10 secretion were significantly reduced upon STING knockdown, whereas no significant differences were found upon TLR9 silencing ( Figures 6A and 6B ). This effect was specific to IFNa, because STING knockdown did not affect HLA-DR and CD86 expression or CXCL10 secretion by monocytes treated with IL-4.
Interestingly, STING knockdown substantially reduced IFNa-mediated IL6 secretion while TNFa secretion was also reduced but did not reach statistical significance (p = 0.0626) (Figure 6C) , suggesting that STING sensing can control type I interferon-mediated response to immunogenic nucleic acid presence in the cytoplasm. These results are in line with the upregulated expression of STING observed in SLE monocytes ( Figure 6D ) and recapitulate the effect of mTORC1 inhibition, lysosomal reacidification, and mtROS scavenging upon IFNa signaling.
Finally, to confirm that the cytosolic escape of mtDNA from autolysosomes is sensed by STING upon IFNa signaling, we transfected monocytes with acidity-independent DNase I protein using DOTAP transfection reagent, a lipoplex that is internalized by the clathrin-mediated endocytosis pathway and targeted to the lysosomal compartment (Rejman et al., 2005) . Transfection of DNase I reduced the autoinflammatory IFNa-mediated increase in antigen presenting capacity of monocytes based on HLADR and CD86 expression as compared to the delivery of heat inactivated DNase I ( Figure 6E ). These data confirm that ineffective degradation of a lysosomal nucleic acid substrate is being sensed and drives the response.
DISCUSSION
A rational development of alternative, targeted therapies for a systemic autoimmune disease requires the comprehensive understanding of the pathogenic molecular mechanisms whose reversal may lead to restoration of homeostasis. Defective clearance and accumulation of biological waste together with self-DNA sensing and excessive IFNa production drive SLE pathogenesis (Crow, 2014; Niewold et al., 2007; Pascual et al., 2006; Tsokos, 2016) . In this context, additional insight has been gained into our understanding of the innate immune pathways and sensors that are responsible for instigating self-DNA triggered autoinflammatory events in immune cells (Caielli et al., 2016; Oka et al., 2012; Shrivastav and Niewold, 2013) . Nonetheless, whether and how sustained IFNa signaling may affect the continuous production of these self-DNA DAMPs to perpetuate the autoimmune response governing SLE remains elusive. Our work suggests a critical role for IFNa-mediated accumulation of mtDNA in SLE monocytes that escapes autophagic clearance and acts as a cell-autonomous cytoplasmic DAMP. Its sensing and activation of STING results in enhanced MHCII and CD86 expression and secretion of TNFa and IL6, enabling them to launch immunity to self-DNA and to promote the clonal expansion of autoreactive lymphocytes.
Our findings demonstrated that IFNa induces autophagy in naive CD14
+ monocytes, an observation in line with the reported induction of autophagy by type I IFNs in several cancer cell lines (Schmeisser et al., 2013; Zhu et al., 2015) . In silico analysis of the human LC3B promoter indicated the presence of Stat and IRF binding sites and LC3B gene transcripts were found upregulated in IFNa-treated monocytes ( Figure S4 ), suggesting the possibility of a direct transcriptional regulation of autophagy components by IFNa. In addition to the induction of autophagy, IFNa impairs the completion of autophagic flux, monocytic lysosomes fail to properly acidify, leading to decreased digestion of lysosomal substrates and to accumulation of damaged autophagy substrates in the cytoplasm that are being sensed. Analysis of TFEB expression levels and nuclear localization, a transcription factor that controls the lysosomal-autophagic pathway (Settembre et al., 2011) and drives lysosomal biogenesis, together with the quantification of LAMP1 puncta per cell showed no difference in SLE and upon IFNa treatment ( Figure S5 ), further confirming that deficiency in autophagic degradation is a result of deregulated lysosomal activity. Our data dissect a metabolic pathway triggered by IFNa that results in deceleration of lysosomal digestion through changes of its pH regulation. In accordance with a previous study using SLE PBMCs (Gergely et al., 2002b) , we observed that SLE monocytes harbor lower ATP and higher mtROS levels, indicative of high mitochondrial membrane potential that results from deregulated OXPHOS ( Figure S6 ). Our RNA-seq data from SLE monocytes with high IFNa signature implicate disrupted mitochondrial metabolism, oxidative stress, and alterations in ionic channels as well as in the regulation of endosomal pH. In a state of mitochondrial hyperpolarization, as that seen in SLE PBMCs, H + ions are extruded from the mitochondrial matrix within the electron transport chain (ETC)-and cytochromes become reduced, promoting production of ROS and generating oxidative stress, as indicated by the upregulation of AXL, FASLG, HERC5, ABTB2, ETS1, FBXO2, HERC6, IL1A, PARP15, PARP9, SPSB1, and TRIM69 genes in SLE monocytes. Immunometabolism is an emerging frontier in immunology (Mathis and Shoelson, 2011 ). SLE T cell survival and hyperactivation is known to be supported by intensive OXPHOS (Wahl et al., 2012) . Normalization of CD4 + T cell metabolism in lupus prone mice was proposed as a promising strategy to reverse lupus pathology (Yin et al., 2015) . OXPHOS and its products, ATP and mtROS, are major determinants of intracellular oxidation and regulating cellular activation, differentiation, and survival. The same mitochondrial respiration byproducts modulate autophagy and its flux. mTOR is a mitochondrial membrane DJm sensor that can be activated in a redox or ATP-dependent fashion, and its blockade has emerged as an effective approach to reverse T cell activation (Pearce et al., 2013; Sena et al., 2013; Yin et al., 2015) . Residing on lysosomal membrane, mTORC1 subunit of mTOR possesses the capacity to regulate lysosomal pH and to determine its functionality (Korolchuk et al., 2011) . Metabolic regulation of lysosomal function impacts on the resolution of autophagic degradation, affecting the fate of its substrates while modulating immune cell activation and differentiation (Chen et al., 2008) . Our study provides a previously uncharacterized mechanism and unravels components affecting monocyte immunometabolism in human SLE, which could be exploited as an adjunct therapy to expedite remission and prevent disease flares. Acidic nanoparticles are used as tools to correct effects of aberrant immunometabolism, emerging as a more selective option for SLE treatment. PLGA aNPs, in particular, might also be degraded, their derivatives (lactic and glycolic acids) can support Dc mt. , and their action remains unchanged upon hydroxychloroquine presence, a major drug for the treatment for lupus management.
Metabolic rescue of IFNa-dependent deregulation of lysosomal acidification results in completion of autophagy and decreases the immunogenic potential of IFNa-induced monocytes. IFNa signaling directly affects mitochondrial function and OXPHOS as indicated by the increased presence of Stat1 in mitochondria of IFNa-treated monocytes ( Figure S6 ) that has been previously reported to affect Dc m . explaining-at least in partthe observed SLE mitochondrial hyperpolarization followed by increased generation of mtROS and reduced ATP. Oxidative stress is sensed as indicated by the upregulation of ROS-responding PINK1 gene, autophagy is induced, but IFNa-mediated lysosomal dysfunction impedes mitochondrial clearance leading to cell autonomous mtDNA accumulation that activates STING and prepares monocytes to defend against improperly localized bacterial-like nucleic acids. The observed functional restoration of lysosomal degradation and the resulting amelioration of their inflammatory phenotype suggest that mTORC1 inhibition can revert the inflammatory function of IFNa-shaped monocytes. Similar effects were attained by targeting any step of the proposed mechanism such as mtROS through scavenging, lysosomal pH through acidification by PLGA aNPs, DNA digestion through DNase I transfection into lysosomes, or STING knockdown in IFNa-shaped monocytes, thus hampering the IFNa-mediated differentiation of blood monocytes into DC-like APCs.
Inhibitors of mTOR, such as sirolimus and everolimus, are effective as part of triple immunosuppression regimens for the prevention of kidney transplant rejection-with their main advantages being the absence of nephrotoxicity and reduced occurrence of malignancies. The use of mTOR inhibitors in SLE (both human and murine) reduced severity of nephritis and general activity of the disease as well as antiphospholipid antibody production and vascular lesions associated with the antiphospholipid syndrome (Bride et al., 2016; Canaud et al., 2014; Oaks et al., 2016) . Recent data from a multicenter trial suggest that rapamycin is effective in relapsed/refractory autoimmune cytopenias (Chen and Fang, 2002) . In spite of these encouraging results, the role of mTOR inhibition in the treatment of SLE needs to be better documented. To date, their beneficial effects have been ascribed to their Results are expressed as mean +SEM. *p < 0.05, **p < 0.005. Datasets were analyzed using paired Student's t test apart from (D) that was analyzed using non-parametric Mann-Whitney U test.
abrogating effects on mTOR activation in renal vascular endothelial cells and the normalization of T cell activation-induced calcium fluxing (Crow and Manel, 2015) . Herein, we demonstrate an additional effect on lysosomal clearance in SLE monocytes-a critical event in both the initiation and relapse of the disease. Our study established that mitochondrial hyperpolarization observed in SLE monocytes can be mediated by IFNa stimulation that activates a mechanism coupling cytokine signaling with OXPHOS. Reversal of IFNa-dependent intracellular oxidation using scavenger of mtROS represents an additional target to be assessed for its efficacy in achieving durable remission, a major goal in SLE management. Antioxidant mtROS scavengers are currently being investigated in several diseases associated with mitochondrial dysfunction and oxidative stress such as antiphospholipid syndrome, multiple sclerosis, and vasculitis. Their efficiency in maintaining the homeostasis of neuronal and endothelial cells, while they simultaneously act as mild immunosuppressants, makes them attractive candidates to prevent or improve SLE pathology including renal, neuropsychiatric, and musculoskeletal manifestations.
Multi-targeted therapy is necessary to induce remission and prevent flares of SLE. Our data suggest unanticipated benefits of targeting IFNa in SLE and reveal additional downstream therapeutic targets that make break the ''vicious'' cycle of aberrant nucleic acid sensing in lupus monocytes, and thus may promote a deeper and a more durable remission in this disease. Development of sophisticated tools and approaches to in vivo regulate molecular aberrations that drive pathology can open the way to prevent and methodically treat complex human diseases.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Katerina Gkirtzimanaki (kgirtzimanaki@gmail.com) .
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Subjects 49 SLE patients followed by the Rheumatology Clinic of the University Hospital of Crete, diagnosed according to the American College of Rheumatology 1982 classification criteria were studied (median age = 42.5 years; range: 16 to 70yrs). Active SLE was defined as an SLE Disease Activity Index 2000 score (SLEDAI-2K) higher than 8 at the day of blood draw. Patients were abstained from their medications -including steroids and CQ -for at least 24 hours prior to blood sampling. Moreover, n = 26 patients were completely off therapy at the time of enrolment to the study. Healthy age-and sex-matched volunteers from the Department of Transfusion Medicine of the University Hospital of Heraklion served as controls. 6 patients followed by the Rheumatology Clinic of the University Hospital of Crete, diagnosed with Rheumatoid Arthritis according to the 1987 American College of Rheumatology (ACR) criteria, donated peripheral blood that served as control serum treatment (median age = 45.4 years). The study was approved by the Ethics Committee of the University Hospital of Heraklion and all subjects gave written informed consent prior to study (Protocol Number: 5944/14-6-2017) . Sex/gender, age and clinical records of SLE patients are listed in Table S1 (excel file) and of RA patients in Table S2 . Criteria of patient selection were disease activity (SLEDAI) and ability to abstain from therapy.
METHODS DETAILS
Peripheral blood monocyte isolation PBMCs were isolated from heparinized human peripheral blood by Ficoll-Histopaque-1077 (GE-Healthcare) density centrifugation. Erythrocytes were eliminated by hypotonic lysis (1ml ddH2O for 25 s and 1ml 1.8% NaCl). Viability was measured 99% by trypan blue dye exclusion in every experiment. Monocytes were magnetically isolated (MACS, Miltenyi Biotec) and purity was evaluated by flow cytometry (CD14 + cells/total live cells). Preparations of R 94% purity were used in all experiments.
Serum collection
Healthy, SLE and RA peripheral blood samples were collected in SST vacutainers and centrifuged at 2500 rpm for 15mins (RT). Serum was collected under sterile conditions and stored in aliquots at À80 C.
Cell culture
Magnetically isolated CD14 + monocytes were cultured in RPMI-1640/L-glutamine, supplemented with 10% heat-inactivated FBS, 100 IU/mL penicillin and 100 mg/mL streptomycin for up to 24hours. When longer culture time was necessary, cells were cultured for 3 days and medium was further supplemented with GM-CSF (100 ng/ml, Peprotech) and Peprotech) C and 5% CO 2 ). Mitochondrial membrane polarization was assessed by JC-1 (eBiosciences) staining (1 mg/ml for 10min at 37 C and 5% CO2) and lysosomal re-acidification by aNPs was assessed using.Lysosensor DND189 (Thermo Scientific) staining (1mM in medium for 20min at 37 C and 5% CO2). Samples were acquired on a FACSCalibur (BD Biosciences) and analyzed using the FlowJo software (Tree Star). For phospho-protein staining, cells were permeabilized and stained using the Intracellular Fixation and Permeabilization Buffer Set kit (eBioscience), according to manufacturer instructions.
Mixed Lymphocyte Reaction
Human cord blood (CB) was obtained from normal deliveries by the Ob/Gyn Dpt of the University Hospital of Heraklion. CB was collected in a heparinized tube following delivery of the infant and clamping and transecting of the umbilicus. CD4 + CD25 -T cells were magnetically isolated (Miltenyi, CD4 + CD25 + Treg isolation kit 130-091-301, negative selection) by CB PBMCs (puriy R 85%) and CFSE labeled (Thermo Fisher Scientific, Cell Trace C34554). Allogeneic monocytes (Miltenyi, Monocyte isolation kit II,130-091-153, negative selection) were isolated from unrelated adult PBMC donors (puriy R 94%) 1 day prior to CB donation in the cases of healthy donors or the same day in the cases of SLE patients; HLA typing was not done. Healthy CD14 + PBMCs were pretreated for 18hrs with the following reagents, alone or in combination: Universal Type I IFN (IFNa), Rapamycin and CQ and washed before being added to the MLRs. SLE monocytes were pretreated for 1hr with rapamycin where indicated. 10 5 pretreated monocytes were plated in round-bottomed 96-well plates and 5x10 4 CFSE labeled T cells were added; MLRs were left in culture for 6 days in a humidified 37 C and 5% CO 2 incubator. Every MLR culture was performed in triplicate. Proliferation index was calculated using FlowJo software platform.
DNase I Transfection
CD14
+ PBMCs were transfected with 1.5 mg of DNase I (Roche) or Heat Inactivated DNase I (75 C for 10 min/U) using DOTAP transfection reagent (Roche) according to manufacturer's instructions. After incubation with DOTAP-DNase I or DOTAP-HIDNase I for 3 hours (transfection mix was added in culture medium), cells were washed to remove excess of transfection reagent and enzyme, stimulated with IFNa and incubated for 18hrs or GMCSF 100ng/ml and IFNa 400ng/ml or IL4 20ng/ml and incubated for 3 days. HLA-DR and CD86 markers were analyzed by flow cytometry.
Electroporation of primary monocytes with siRNAs CD14 + PBMCs were isolated from blood specimens not older than 2hrs and incubated for 1hr in RPMI-1640 containing FBS 10%, streptomycin 100 mg/ml, penicillin 100 U/ml, Glutamine 2mM and sodium pyruvate 1mM, in a humidified 37 C/5% CO 2 incubator before electroporation. 10 6 cells/sample were electroporated with 90nM (3 3 30nM) Stealth RNAi siRNA duplexes using Amaxa Human Dendritic Cell Nucleofector Kit. Cells were incubated with transfection mix in medium for 6hrs and were then washed and incubated for 3 days with GMCSF and IFNa or IL4. All transfection experiments were performed in triplicates (biological replicates) for all conditions. Transfection efficiency was assessed by flow cytometry for GFP in cells transfected with 5 mgs pmaxGFPâ Vector (65%-75% efficiency).
RNA-sequencing library preparation RNA was isolated from CD14 + PBMCs of 7 patients and 5 healthy controls. RNA-sequencing libraries were prepared with the TruSeq RNA kit using 1 mg total RNA according to Illumina's protocols. All 12 samples were pooled together and mixed in equal amounts. Samples were sequenced in the Greek Genome Center (GGC) at BRFAA. Paired-end 40bp reads were generated with the NextSeq500.
RNA Sequencing library analysis
Raw sequencing data were aligned to the human genome GRCh37/hg19 with the use of tophat2 (version 2.0.9) (Kim et al., 2013) and «-b2-very-sensitive» parameter. Samtools (version 0.1.19) (Li et al., 2009) were used for data filtering and file format convertion while HT-seq count (version 0.6.1p1) (Anders et al., 2015) was utilized for assigning aligned fragments into exons using the « -s -no -m intersection -nonempty » command. Differential expression was performed with DESeq R package (Anders and Huber, 2010) and genes with fold change cut off 1.5 and p value % 0.05 were considered to be differentially expressed (DEGs) between the 5 healhty and 7 patients (Table S3) . Gene ontology and pathway analysis was performed in the DEGs with DAVID knowledgebase (Huang et al., 2009 ) Data have been deposited in the Short Read Archive (SRA) under the BioProject PRJNA392602.
Acidic nanoparticle (aNP) preparation
Resomer â RG 503H PLGA (Sigma-Aldrich, 719870) was used with a lactide-glycoside ratio of 50:50, Molecular weight 24000 to 38000. A stock solution of polymer was prepared by dissolving 31 mg of PLGA in 3.1 mL of THF (Sigma-Aldrich, 401757). 200 mL of this stock solution were added to 20 mL of deionized water under sonication. The suspension of PLGA-aNP was then slowly the manufacturer's recommendations. Light absorbance was measured using an ELx800 Biotek plate reader. Background signal was subtracted. All samples were assessed in duplicates (technical replicates).
ATP Assay CD14 + monocytes (10 6 cells /condition) were harvested, washed and lysed according to manufacturer's protocol (Abcam) for the colorimetric assay. Light absorbance was measured using an ELx800 Biotek plate reader. ATP levels were calculated according to the formula given: [ATP] (nmol per mL or mM) = (Ts/Sv) * D, Ts = ATP amount from standard curve (nmol or mM), Sv = sample volume added in sample wells (mL), D = sample dilution factor.
Isolation of mitochondria
Mitochondria were isolated from cultured cells with the Mitochondria Isolation Kit, Thermo Fisher Scientific (89874) according to manufacturer's protocol. Briefly, cells were lysed using the reagent based method following the instructions to obtain a more purified fraction of mitochondria, with > 50% reduction of lysosomal and peroxisomal contaminants. For Western Blot analysis mitochondrial pellets were boiled with SDS-PAGE sample buffer: RIPA buffer supplemented with phosphatase and protease inhibitors (ThermoFisher Scientific) and additional SDS (20%) and b-mercaptoethanol (5%).
Cathepsin D activity detection
Cathepsin D activity was measured by the Fluorometric Assay Kit from Abcam (ab65302), according to manufacturer's instructions. Briefly, 10 6 cells were harvested for each condition, lysed immediately and incubated with the preferred cathepsin-D substrate GKPILFFRLK(Dnp)-D-R-NH2, labeled with MCA. Fluorescence released upon substrate cleavage was measured in a FLx800 fluorescence microplate reader. For all experiments, cell lysates were assayed as freshly prepared.
Oxygen consumption rate measurements Oxygen consumption rates were measured as described by Palikaras et.al. at Nature 2015, using a Clark-type electrode (Hansatech Instruments). 4x10 6 CD14 + monocytes treated as indicated were washed and collected in PBS buffer. The chamber was kept at 37 C and measurements were done for 10-15 min, depending on the oxygen consumption rate. The slope of the straight portions of the plots were used to derive the oxygen consumption rates. Cells were recovered after respiration measurements and collected for protein quantification. Rates were normalized to protein content as calculated by Bradford protein assay.
Reagents Plaquenil (CQ: 46.1 mM) was purchased from Sanofi Aventis. Rapamycin (Rapam.:1 mM) was from SIGMA. Wortmanin (WM:1mM) was purchased from InvivoGen. Mitotracker CMXRos (MTR: 1 mM), MitoTEMPO (2nM), Lysotracker-DND99 (LTR: 1mM) and MitoSOX (5mM) were purchased from Molecular Probes -Thermo Fisher Scientific. JC-1 (2 mgs/ml) was purchased from eBiosciences. Recombinant DNase I and DOTAP liposomal transfection reagent were obtained from Roche. Human STING (TMEM173), TLR9 and Negative Stealth siRNA duplex oligonucleotides were purchased from Invitrogen.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical Analysis
Results are presented as mean ± SEM. Statistical analysis was performed using paired Student's t test or unpaired non-parametric Mann Whitney U test, as indicated in each Figure legend . All experiments were performed in the number of biological replicates mentioned as n in each Figure Legend . Briefly, experiments performed in different healthy donors (n corresponds to the number of healthy donors) were designed to assess the effect of different treatments assessing one donor / experiment. In this case, statistical analysis was performed using paired t test, while comparison of healthy with SLE samples was statistically analyzed using unpaired Student's t test (non-parametric Mann Whitney). A P value < 0.05 was considered to indicate statistical significance (*). All data were analyzed using GraphPad Prism software.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-sequencing data reported in this paper is NCBI Short Read Archive: PRJNA392602 (https://www. ncbi.nlm.nih.gov/bioproject/PRJNA392602/).
